Download PDF
1 / Pages

Other users also viewed these articles

Predictive Factors of Severe Behçet's disease: A Longitudinal, Prospective Cohort Followed Between 1981¿2020 Luísa Serpa Pinto; Sara Xavier Pires; Berta Silva; Fátima Farinha; Carlos Vasconcelos; João Araújo Correia;
Reumatol Clin. 2022;18:410-5
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab Juan José Lerma Garrido; Antonio Gracia Pérez; Antonio Pérez Torres; Amalia Rueda Cid; Clara Molina Almela; María Dolores Pastor Cubillo; Cristina Campos Fernández; Isabel Balaguer Trull; Loreto Carmona; Javier Calvo Catalá;
Reumatol Clin. 2022;18:25-9
SER recommendations on treatment of refractory Behçet's syndrome Clara Moriano Morales; Jenaro Graña Gil; Noé Brito García; José Luis Martín Varillas; Vanesa Calvo del Río; Patricia Moya Alvarado; Francisco Javier Narváez García; Gerard Espinosa; Petra Díaz del Campo Fontecha; Mercedes Guerra Rodríguez; José Mateo Arranz; Manuela López Gómez; Félix Manuel Francisco Hernández; M. Mar Trujillo; Raquel dos Santos Sobrín; Juan Ignacio Martín Sánchez; Jesús Maese Manzano; Julio Suárez Cuba;
Reumatol Clin. 2024;20:204-17